Truist Financial Lowers PT on AbCellera Biologics (ABCL) to $10 From $28, Keeps a Buy Rating

Reported about 10 hours ago

Writing summary...

Source: YAHOO

View details

You may also interested in these wikis

Jim Cramer Praises Wells Fargo's Performance
Jim Cramer Predicts Palantir Technologies Inc. (PLTR) Could Rise in H2 2025
Capgemini to Acquire WNS for $3.3 Billion
Alcon Inc (ALC) Receives Approval for Clareon PanOptix Pro Intraocular Lens
Consequences of a Returned Card Payment
Brex Adapts to AI Evolution by Embracing Flexibility
Pony.ai Launches Robotaxi Trials in Dubai Set for Late 2025
H.C. Wainwright Maintains Buy Rating for Opko Health, Price Target Set at $3
Waymo starts robotaxi testing in Philadelphia and NYC
Jim Cramer Critiques Apple Inc.'s Stock Buybacks Amid Investment Concerns
Back to all Wikis